| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCPH.1149 |
| P8608 | Fatcat ID | release_mzgxaowb35gsbiwkebuqv7t7ca |
| P932 | PMC publication ID | 6175224 |
| P698 | PubMed publication ID | 29746707 |
| P50 | author | Tomoki Takechi | Q96246426 |
| P2093 | author name string | Tsuyoshi Kaneko | |
| Ichiro Ieiri | |||
| Takeshi Higuchi | |||
| Rumiko Kato | |||
| Tadao Kumokawa | |||
| P2860 | cites work | Developmental expression of human hepatic CYP2C9 and CYP2C19. | Q44666457 |
| Plasma propranolol levels in adults With observations in four children | Q45077479 | ||
| Differences in plasma binding of drugs between Caucasians and Chinese subjects. | Q51731148 | ||
| Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. | Q51766049 | ||
| Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method. | Q51911138 | ||
| Efficacy and safety of oral propranolol for infantile hemangioma in Japan. | Q53500320 | ||
| Comparison of Infantile Hemangiomas in Preterm and Term Infants: A Prospective Study | Q60607675 | ||
| Disposition of propoxyphene and propranolol in children | Q67443845 | ||
| Pharmacokinetics of propranolol | Q71008655 | ||
| Binding of oxprenolol and propranolol to serum, albumin and alpha 1-acid glycoprotein in man and other species | Q71419738 | ||
| Propranolol disposition in Chinese subjects of different CYP2D6 genotypes | Q71731573 | ||
| Alterations in theophylline metabolism during the first year of life | Q72561435 | ||
| Propranolol plasma monitoring in children submitted to surgery of tetralogy of Fallot by a micromethod using high performance liquid chromatography | Q80522134 | ||
| PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. | Q33219671 | ||
| A comparison of the pharmacokinetics of propranolol in obese and normal volunteers | Q34447655 | ||
| Ontogeny of dextromethorphan O- and N-demethylation in the first year of life | Q34575597 | ||
| A randomized, controlled trial of oral propranolol in infantile hemangioma. | Q34668015 | ||
| Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences | Q35238375 | ||
| Treatment of infantile haemangiomas: recommendations of a European expert group | Q35645474 | ||
| Diagnosing model diagnostics | Q36850144 | ||
| Mechanism-based concepts of size and maturity in pharmacokinetics | Q36960112 | ||
| Infantile haemangioma | Q39089425 | ||
| Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration | Q39794295 | ||
| Quantitative account of propranolol metabolism in urine of normal man. | Q41390378 | ||
| Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma | Q41940414 | ||
| Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein | Q42494665 | ||
| Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. | Q44464274 | ||
| Propranolol concentrations after oral administration in term and preterm neonates. | Q44663019 | ||
| P433 | issue | 10 | |
| P921 | main subject | pharmacodynamics | Q725307 |
| P304 | page(s) | 1361-1370 | |
| P577 | publication date | 2018-05-10 | |
| P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
| P1476 | title | Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma. | |
| P478 | volume | 58 |
Search more.